Kronos Bio Inc. (NASDAQ: KRON)
$1.44
-0.0600 ( -4.00% ) 72.3K
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
Market Data
Open
$1.44
Previous close
$1.50
Volume
72.3K
Market cap
$87.74M
Day range
$1.43 - $1.51
52 week range
$0.69 - $2.28
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 01, 2024 |
8-k | 8K-related | 13 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 26, 2024 |